PHR insider filing: Restricted stock sale planned for 2,051 shares

Rhea-AI Filing Summary

Form 144 filed for Phreesia, Inc. (PHR) reports a proposed sale of 2,051 common shares through Fidelity Brokerage Services on the NYSE, with an aggregate market value of $47,756.30 and an approximate sale date of 09/16/2025. The shares were acquired on 09/11/2025 as restricted stock that vested and were received as compensation. The filer certifies no undisclosed material adverse information. The filing also discloses recent open-market sales by insiders in the past three months, including large disposals by David Linetsky totaling 41,174 shares across June–August 2025 and smaller sales by Jessica Weiss.

Positive

• Clear provenance of the securities: shares were acquired as restricted stock vesting and received as compensation on 09/11/2025.
• Required attestation included: filer represents no undisclosed material adverse information, consistent with compliance norms.

Negative

• Recent large insider sales by David Linetsky (23,729 and 17,445 shares) reported in the past three months could attract investor attention.
• Form lacks context about any trading plan adoption dates or rationale for the sales beyond vesting, limiting interpretability.

Insights

Securities Analyst

TL;DR Routine insider sale of vested restricted stock; modest in size relative to outstanding shares, but notable prior insider disposals.

The proposed sale of 2,051 shares for $47,756.30 is a typical disposition of recently vested restricted awards and is documented under Rule 144. Relative to the issuer's 59,914,473 shares outstanding, the planned sale is immaterial on a share count basis. However, the filing should be read alongside recent insider sales: David Linetsky sold 23,729 and 17,445 shares in June and August 2025 respectively, representing larger cash realignments by that insider. No financial results or forward-looking statements are included.

Corporate Governance Expert

TL;DR Compliance-focused disclosure showing adherence to Rule 144 and insider certification; no governance red flags disclosed.

The form documents the provenance of the securities as restricted stock vesting and records the filer’s attestation regarding material nonpublic information. The filing format and statements align with standard governance and compliance practice for executive or employee equity dispositions. There is no mention of any trading plan dates or other conditional instructions, and no regulatory exceptions or disclaimers beyond the required attestation are provided.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	2051	47756.30	59914473	09/16/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/11/2025	Restricted Stock Vesting	Issuer			2051	09/11/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Jessica Weiss 1521 Concord Pike Suite 301 PMB 221 Wilmington DE 19803	Common	06/17/2025	42	1057.23
Jessica Weiss 1521 Concord Pike Suite 301 PMB 221 Wilmington DE 19803	Common	06/18/2025	67	1715.96
David Linetsky 1521 Concord Pike Suite 301 PMB 221 Wilmington DE 19803	Common	06/27/2025	23729	676195.48
David Linetsky 1521 Concord Pike Suite 301 PMB 221 Wilmington DE 19803	Common	07/17/2025	2063	55465.41
Jessica Weiss 1521 Concord Pike Suite 301 PMB 221 Wilmington DE 19803	Common	08/18/2025	78	2274.13
David Linetsky 1521 Concord Pike Suite 301 PMB 221 Wilmington DE 19803	Common	08/22/2025	17445	518681.81

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Phreesia (PHR) Form 144 filed on 09/16/2025 disclose?

The form reports a proposed sale of 2,051 common shares via Fidelity with an aggregate market value of $47,756.30, acquired as restricted stock vesting on 09/11/2025.

Who is selling the shares and through which broker?

The filing lists the sale to be executed through Fidelity Brokerage Services LLC on the NYSE.

Are there other insider sales disclosed recently for PHR?

Yes. The filing lists recent sales in the past three months including David Linetsky selling 23,729 and 17,445 shares and Jessica Weiss selling several smaller lots.

Were the shares acquired by purchase or compensation?

The 2,051 shares were acquired on 09/11/2025 as restricted stock vesting and the consideration is listed as compensation.

How material is the proposed sale relative to total shares outstanding?

The proposed 2,051-share sale is immaterial relative to the reported 59,914,473 shares outstanding, based solely on disclosure in this filing.